Emergence of the novel SARS-CoV-2 lineage P.4.1 and massive spread of P.2 in South Brazil

Fernando HayashiSant’Anna,Ana PaulaMuterle Varela,JaniraPrichula,JulianaComerlato,Carolina BaldisserottoComerlato,Vinicius SerafiniRoglio,Gerson FernandoMendes Pereira,FláviaMoreno,AdrianaSeixas,ElianaMárcia Wendland

doi: https://doi.org/10.1101/2021.04.14.21255429

Fernando Hayashi Sant’Anna

1Hospital Moinhos de Vento, PROADI – SUS, Porto Alegre,Brazil

Ana Paula Muterle Varela

2Graduate Program in Biosciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre,Brazil

Janira Prichula

2Graduate Program in Biosciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre,Brazil

Juliana Comerlato

1Hospital Moinhos de Vento, PROADI – SUS, Porto Alegre,Brazil

Carolina Baldisserotto Comerlato

1Hospital Moinhos de Vento, PROADI – SUS, Porto Alegre,Brazil

Vinicius Serafini Roglio

1Hospital Moinhos de Vento, PROADI – SUS, Porto Alegre,Brazil

Gerson Fernando Mendes Pereira

3Department of Chronic Conditions and Sexually Transmitted Infections, Ministry of Health, Brasília,Brazil

Flávia Moreno

3Department of Chronic Conditions and Sexually Transmitted Infections, Ministry of Health, Brasília,Brazil

Adriana Seixas

2Graduate Program in Biosciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre,Brazil

Eliana Márcia Wendland

1Hospital Moinhos de Vento, PROADI – SUS, Porto Alegre,Brazil

4Department of Community Health, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre,Brazil

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence:elianawend{at}gmail.com

ABSTRACT

South Brazil has been the novel epicenter of Coronavirus Disease 2019 (COVID-19) in 2021, accounting for the greatest number of cumulative cases and deaths (per 100 thousand inhabitants in a week) worldwide. In this study, we analyzed 340 whole genomes of SARS-CoV-2, which were sampled between April and November 2020 in 33 cities in South Brazil. We demonstrated the circulation of two novel emergent lineages, described here as P.4 and P.4.1 (provisionally termed VUI-NP13L), and seven lineages that had already been assigned (B.1.1.33, B.1.1.28, P.2, B.1.91, B.1.1.94, B.1.195 and B.1.212). P.2 and P.4.1 demonstrated massive spread from approximately September/October 2020. Constant and consistent genomic surveillance is crucial to identify newly emerging SARS-CoV-2 lineages in Brazil and to guide decision making in the Brazilian Public Healthcare System.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The Brazilian Ministry of Health along with Moinhos de Vento Hospital, through the Program for Supporting the Institutional Development of Public Health System (PROADI-SUS), financed the study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Institutional Review Board of Moinhos de Vento Hospital under protocol number 32149620.9.0000.5330.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes